Table of Contents Table of Contents
Previous Page  345 / 1241 Next Page
Information
Show Menu
Previous Page 345 / 1241 Next Page
Page Background

What’s next ?

Use the PET to build our future clinical trials :

• End of « One dose fits all »

• De-escalation for small tumors / intensification for

locally advanced tumors

• individualize radiotherapy planning with SUV

dependant dose painting ?

And what about FDG-PET/MRI ?

We need prospective studies to confirm the place of

FDG-PET/CT in response assessment and prognostic